Allogeneic iPSC-derived γδT cells demonstrate antitumor efficacy against patient-derived tissues
Stem Cell Reports · 2026
DOI: 10.1016/j.stemcr.2026.103018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2026. Verfasst von Ryoko Futai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Stem Cell Medicine, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan; Division of Gastroenterology, Department of Interna…. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Colorectal Neoplasms, Receptors, Antigen, T-Cell, gamma-delta, Intraepithelial Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Science and Technology Agency, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Various immunotherapies have been developed to treat malignant tumors, and autologous CAR-T cell therapy is clinically used for certain malignancies. However, their efficacy against solid tumors is limited. γδT cells are recognized for their potent tumor cytotoxicity and MHC-unrestricted activity. We successfully induced γδT cells from iPS cells and demonstrated their cytotoxicity against colorectal cancer cell lines in vitro. However, cancer cell lines often lack critical tumor characteristics such as heterogeneity and drug sensitivity. In contrast, patient-derived cancer organoids retain many features of the patient's tumor tissues. This study evaluated the cytotoxicity of allogeneic iγδT cells against cell lines and organoids, in vitro and in vivo. iγδT cells showed 70%-90% cytotoxicity against cell lines and organoids in vitro. In vivo, local and intravenous administration of iγδT cells suppressed tumor growth by 70%-100%, highlighting their potential as a novel immunotherapy for colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Stem Cell Medicine, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan; Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe Universi…
- Division of Stem Cell Medicine, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan; Division of Advanced Medical Science, Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Hyogo…
- Division of Stem Cell Medicine, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan.
- Division of Stem Cell Medicine, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan; Division of Urology, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan.
- Division of Stem Cell Medicine, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan; Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe, Hyogo, J…
- Division of Gastrointestinal Surgery, Department of Surgery, Graduate School of Medicine, Kobe University, Kobe, Hyogo, Japan.
Förderung
- Japan Science and Technology Agency
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Futai, R., Koyanagi-Aoi, M., Nakahashi, A., Katsura, D., Horikawa, M., Horie, K., Kakeji, Y., Kodama, Y., & Aoi, T. (2026). Allogeneic iPSC-derived γδT cells demonstrate antitumor efficacy against patient-derived tissues. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2026.103018
Vancouver
Futai R, Koyanagi-Aoi M, Nakahashi A, Katsura D, Horikawa M, Horie K, et al. Allogeneic iPSC-derived γδT cells demonstrate antitumor efficacy against patient-derived tissues. Stem Cell Reports. 2026. doi:10.1016/j.stemcr.2026.103018
BibTeX
@article{Futai2026,
author = {Futai, Ryoko and Koyanagi-Aoi, Michiyo and Nakahashi, Aito and Katsura, Daiki and Horikawa, Manabu and Horie, Kazumasa and Kakeji, Yoshihiro and Kodama, Yuzo and Aoi, Takashi},
title = {Allogeneic iPSC-derived γδT cells demonstrate antitumor efficacy against patient-derived tissues},
journal = {Stem Cell Reports},
year = {2026},
doi = {10.1016/j.stemcr.2026.103018}
}
EUVIMED